| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.001 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.083 | 0.003 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.003 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.003 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |